Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05TKO
|
||||
Former ID |
DIB010271
|
||||
Drug Name |
Retagliptin
|
||||
Synonyms |
DPP4 inhibitors, Shanghai Hengrui Pharmaceutical Co Ltd; SHR-1039; SHR-1040; DPPIV inhibitors (diabetes), Shanghai Hengrui Pharmaceutical Co Ltd; Dipeptidyl peptidase IV inhibitors (diabetes), Shanghai Hengrui Pharmaceutical Co Ltd
|
||||
Indication | Non-insulin dependent diabetes [ICD10:E11.9] | Investigative | [543447] | ||
Company |
Shanghai Hengrui Pharmaceutical Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C1N(CC2C1CNC(=O)C2)C(=O)CC(Cc1c(cc(c(c1)F)F)F)N
|
||||
Target and Pathway | |||||
Target(s) | Dipeptidyl peptidase IV | Target Info | Inhibitor | [543447] | |
KEGG Pathway | Protein digestion and absorption | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.